Local and Regional Therapies for Hepatocellular Carcinoma

HepatologyVolume 73, Issue S1 p. 137-149 Review Local and Regional Therapies for Hepatocellular Carcinoma Roman Kloeckner, Roman Kloeckner orcid.org/0000-0001-5492-4792 Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanySearch for more papers by this authorPeter Robert Galle, Peter Robert Galle orcid.org/0000-0001-8294-0992 Department of Internal Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanySearch for more papers by this authorJordi Bruix, Corresponding Author Jordi Bruix jbruix@clinic.cat orcid.org/0000-0002-9826-0753 Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clínic, IDIBAPS, University of Barcelona, CIBEREHD Barcelona, Barcelona, Spain Address Correspondence and Reprint Requests to: Jordi Bruix, M.D, Ph.D. Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clínic, IDIBAPS, University of Barcelona, CIBEREHD Villarroel 170 Barcelona 08036, Spain E-mail: jbruix@clinic.cat Tel.: 34932279803Search for more papers by this author Roman Kloeckner, Roman Kloeckner orcid.org/0000-0001-5492-4792 Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanySearch for more papers by this authorPeter Robert Galle, Peter Robert Galle orcid.org/0000-0001-8294-0992 Department of Internal Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, GermanySearch for more papers by this authorJordi Bruix, Corresponding Author Jordi Bruix jbruix@clinic.cat orcid.org/0000-0002-9826-0753 Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clínic, IDIBAPS, University of Barcelona, CIBEREHD Barcelona, Barcelona, Spain Address Correspondence and Reprint Requests to: Jordi Bruix, M.D, Ph.D. Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clínic, IDIBAPS, University of Barcelona, CIBEREHD Villarroel 170 Barcelona 08036, Spain E-mail: jbruix@clinic.cat Tel.: 34932279803Search for more papers by this author First published: 18 June 2020 https://doi.org/10.1002/hep.31424Citations: 36 Supported by the Carlos III Health Institute (PI18/00768), Albert Einstein Cancer Center (PI044031), and World Cancer Research Fund/American Institute for Cancer Research (16-0026). Potential conflict of interest: Dr. Galle consults, advises, is on the speakers' bureau, and received grants from Bayer. He consults, advises, and is on the speakers' bureau for Bristol-Myers Squibb, MSD, Sirtex, Lilly, Ipsen, AstraZeneca, and Roche. Dr. Bruix consults and received grants from BTG and Ipsen. He consults for AbbVie, AstraZeneca, Arqule, Roche, Bristol-Myers Squibb, AdaptImmune, Basilea, Eisai, Gilead, Sirtex, Sanofi, Terumo, and Novartis. Dr. Kloeckner consults and advises for Boston Scientific, Bristol-Myers Squibb, Guerbet, Roche, and SIRTEX and is on the speakers' bureau for BTG, Eisai, Guerbet, Ipsen, MSD Sharp & Dohme, and SIRTEX. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume73, IssueS1Special Issue: Cancers of the Liver - Biology, Diagnosis and TreatmentJanuary 2021Pages 137-149 RelatedInformation